FDA Drug recall D-1240-2015
0.9% Sodium Chloride Injection USP, 50 mL ADD-Vantage Unit, Rx only, Manufactured by Hospira, Inc., Ausitn, TX 78728, NDC 00409-7101-68
- FDA Drug
- Class II
- terminated
- Published 2015-07-22
On 2015-07-22 the FDA classified a Class II recall of 0.9% Sodium Chloride Injection USP, 50 mL ADD-Vantage Unit, Rx only, Manufactured by Hospira, Inc., Ausitn, TX 78728, NDC 00409-7101-68 by Hospira, citing lack of assurance of sterility: Potential channel leaks near the threaded vial port.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1240-2015 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2015-07-02 |
| Published | 2015-07-22 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Hospira |
| Distribution | n/a |
Product
0.9% Sodium Chloride Injection USP, 50 mL ADD-Vantage Unit, Rx only, Manufactured by Hospira, Inc., Ausitn, TX 78728, NDC 00409-7101-68
Reason
Lack of assurance of sterility: Potential channel leaks near the threaded vial port.
Identifiers
| code_info | Lot #: 49-084-JT; 49-119-JT |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1240-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.